Related Experiment Video
Updated: Jun 27, 2026

Stimulation of Notch Signaling in Mouse Osteoclast Precursors
Published on: February 28, 2017
Calcium/calmodulin-dependent kinase II regulates notch-1 signaling in prostate cancer cells
Olga A Mamaeva1, Junghyun Kim, Gong Feng
1Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama 35249-7331, USA.
Abstract:
Notch signaling is associated with prostate osteoblastic bone metastases and calcium/calmodulin-dependent kinase II (CaMKII) is associated with osteoblastogenesis of human mesenchymal stem cells. Here we show that prostate cancer cell lines C4-2B and PC3, both derived from bone metastases and express Notch-1, have all four isoforms of CaMKII (alpha, beta, gamma, delta). In contrast, prostate cancer cell lines LNcaP and DU145, which are not derived from bone metastases and lack the Notch-1 receptor, both lack the alpha isoform of CaMKII. In addition, DU145 cells also lack the beta-isoform. In C4-2B cells, inhibition of CaMKII by KN93 or gamma-secretase by L-685,458 inhibited the formation of the cleaved form of Notch-1 thus inhibiting Notch signaling. KN93 inhibited down stream Notch-1 signaling including Hes-1 gene expression, Hes-1 promoter activity, and c-Myc expression. In addition, both KN93 and L-685,458 inhibited proliferation and Matrigel invasion by C4-2B cells. The activity of gamma-secretase was unaffected by KN93 but markedly inhibited by L-685,458. Inhibition of the expression of alpha, beta, or gamma-isoform by siRNA did not affect Hes-1 gene expression, however when expression of one isoform was inhibited by siRNA, there were compensatory changes in the expression of the other isoforms. Over-expression of CaMKII-alpha increased Hes-1 expression, consistent with Notch-1 signaling being at least partially dependent upon CaMKII. This unique crosstalk between CaMKII and Notch-1 pathways provides new insight into Notch signaling and potentially provides new targets for pharmacotherapeutics.
Insights
Calcium/calmodulin-dependent kinase II (CaMKII) interacts with Notch-1 signaling in prostate cancer bone metastasis. Inhibiting CaMKII or gamma-secretase impacts cancer cell proliferation and invasion, suggesting new therapeutic targets.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Signaling
Background:
- Notch signaling is implicated in prostate cancer bone metastases.
- Calcium/calmodulin-dependent kinase II (CaMKII) is crucial for osteoblastogenesis.
- Prostate cancer cell lines exhibit differential Notch-1 receptor and CaMKII isoform expression based on metastatic origin.
Purpose of the Study:
- To investigate the relationship between CaMKII and Notch-1 signaling in prostate cancer bone metastasis.
- To explore the functional consequences of inhibiting CaMKII and Notch signaling on cancer cell behavior.
Main Methods:
- Comparative analysis of Notch-1 and CaMKII expression in prostate cancer cell lines.
- Pharmacological inhibition of CaMKII (KN93) and gamma-secretase (L-685,458).
- siRNA-mediated knockdown and overexpression of CaMKII isoforms.
- Assessment of downstream Notch signaling markers (Hes-1, c-Myc), cell proliferation, and invasion.
Main Results:
- Prostate cancer cells from bone metastases (C4-2B, PC3) express Notch-1 and all CaMKII isoforms, unlike non-metastatic cells (LNcaP, DU145).
- Inhibition of CaMKII or gamma-secretase reduced cleaved Notch-1, Hes-1 expression, and c-Myc levels.
- Both inhibitors suppressed proliferation and Matrigel invasion of C4-2B cells.
- CaMKII-alpha overexpression enhanced Hes-1 expression, indicating CaMKII's role in Notch-1 signaling.
Conclusions:
- A novel crosstalk exists between CaMKII and Notch-1 pathways in prostate cancer bone metastasis.
- CaMKII activity is essential for Notch-1 signaling, proliferation, and invasion in metastatic prostate cancer cells.
- This interaction presents potential therapeutic targets for treating prostate cancer bone metastases.
Related Concept Videos
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...